Shares of Jazz Pharmaceuticals' (JAZZ +15%) jump on a favorable Markman ruling defining the...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Shares of Jazz Pharmaceuticals' (JAZZ +15%) jump on a favorable Markman ruling defining the patent claim terms related to its narcolepsy medication Xyrem. Jefferies analyst Corey Davis says upon first read, the patent construction ruling "seems like a clear win for Jazz."